LIMCH1 inhibits antitumor immunity by upregulating PDL1 in triple-negative breast cancer.

Qiu M, Gao Z, Tian M, Liu Y, Liu J, Zhang Q, Liu R, Wang Y, Zheng X, Hao J, Yang Z, Gao M

Open source

DOI
10.1186/s12964-025-02387-6
Published
2025 Oct 8
Container
Cell communication and signaling : CCS
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12964-025-02387-6,
  title = {LIMCH1 inhibits antitumor immunity by upregulating PDL1 in triple-negative breast cancer.},
  author = {Qiu M and Gao Z and Tian M and Liu Y and Liu J and Zhang Q and Liu R and Wang Y and Zheng X and Hao J and Yang Z and Gao M},
  year = {2025},
  journal = {Cell communication and signaling : CCS},
  doi = {10.1186/s12964-025-02387-6},
  url = {https://doi.org/10.1186/s12964-025-02387-6}
}

RIS

TY  - JOUR
TI  - LIMCH1 inhibits antitumor immunity by upregulating PDL1 in triple-negative breast cancer.
AU  - Qiu M
AU  - Gao Z
AU  - Tian M
AU  - Liu Y
AU  - Liu J
AU  - Zhang Q
AU  - Liu R
AU  - Wang Y
AU  - Zheng X
AU  - Hao J
AU  - Yang Z
AU  - Gao M
PY  - 2025
JO  - Cell communication and signaling : CCS
DO  - 10.1186/s12964-025-02387-6
UR  - https://doi.org/10.1186/s12964-025-02387-6
ER  - 

APA

M, Q., Z, G., M, T., Y, L., J, L., Q, Z., R, L., Y, W., X, Z., J, H., Z, Y., & M, G. (2025). LIMCH1 inhibits antitumor immunity by upregulating PDL1 in triple-negative breast cancer.. Cell communication and signaling : CCS. https://doi.org/10.1186/s12964-025-02387-6

Source records